PD Dr. Marlen Haderlein

Medizinische Fakultät Department of Radiation Oncology

Combination of growth pattern and tumor regression identifies a high-risk group in neoadjuvant treated rectal cancer patients (2017) Jeßberger J, Erlenbach-Wuensch K, Posselt R, Haderlein M, Agaimy A, Fietkau R, Hartmann A, Distel L Journal article Response to 6 cycles of chemotherapy with FOLFIRINOX is predictive of overall survival in patients with locally advanced unresectable pancreatic cancer (2016) Haderlein M, Lubgan D, Lettmaier S, Semrau S, Wolf W, Golcher H, Hohenberger W, Fietkau R Conference contribution High-grade histology as predictor of early distant metastases and decreased disease-free survival in salivary gland cancer irrespective of tumor subtype (2016) Haderlein M, Scherl C, Semrau S, Lettmaier S, Uter W, Neukam FW, Iro H, et al. Journal article Ex Vivo Apoptosis in CD8+ Lymphocytes Predicts Rectal Cancer Patient Outcome (2016) Winkler S, Hoppe P, Haderlein M, Hecht M, Fietkau R, Distel L Journal article Spatial distribution of FoxP3+ and CD8+ tumour infiltrating T cells reflects their functional activity (2016) Posselt R, Erlenbach-Wuensch K, Haas M, Jeßberger J, Buettner-Herold M, Haderlein M, Hecht M, et al. Journal article PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis (2016) Hecht M, Buettner-Herold M, Erlenbach-Wuensch K, Haderlein M, Croner R, Grützmann R, Hartmann A, et al. Journal article Single-cycle induction chemotherapy followed by chemoradiotherapy or surgery in patients with head and neck cancer: What are the best predictors of remission and prognosis? (2015) Semrau S, Haderlein M, Schmidt D, Lell M, Wolf W, Waldfahrer F, Uder M, et al. Journal article Lipiodol injections for optimization of target volume delineation in a patient with a second tumor of the oropharynx: A case report (2015) Haderlein M, Merten R, Stojanovic A, Speer S, Scherl C, Fietkau R, Ott OJ Journal article Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome (2015) Erben P, Brunner K, Hecht M, Haderlein M, Buettner-Herold M, Agaimy A, Fietkau R, et al. Journal article Dose-dependent deterioration of swallowing function after induction chemotherapy and definitive chemoradiotherapy for laryngopharyngeal cancer (2014) Haderlein M, Semrau S, Ott O, Speer S, Bohr C, Fietkau R Journal article